Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Haoxi Health Technology's Days Sales Outstanding for the
six
months ended in Dec. 2025 was 1.31.
Haoxi Health Technology's Days Inventory for the
six
months ended in Dec. 2025 was 0.
Haoxi Health Technology's Days Payable for the
six
months ended in Dec. 2025 was 0.9.
Therefore, Haoxi Health Technology's Cash Conversion Cycle (CCC) for the
six
months ended in Dec. 2025 was 0.41.
Haoxi Health Technology (NAS:HAO) Cash Conversion Cycle Explanation
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
Haoxi Health Technology Cash Conversion Cycle Related Terms
Haoxi Health Technology Cash Conversion Cycle Historical Data
* Premium members only.
The historical data trend for Haoxi Health Technology's Cash Conversion Cycle can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Haoxi Health Technology Cash Conversion Cycle Chart
HAO vs BAOS, DBMM, DRCT: Cash Conversion Cycle Comparison
For the Advertising Agencies subindustry, Haoxi Health Technology's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Haoxi Health Technology Cash Conversion Cycle vs Media - Diversified Industry
For the Media - Diversified industry and Communication Services sector, Haoxi Health Technology's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where Haoxi Health Technology's Cash Conversion Cycle falls into.
Haoxi Health Technology Cash Conversion Cycle Calculation
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
Haoxi Health Technology's Cash Conversion Cycle for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Haoxi Health Technology (HAO) has a Cash Conversion Cycle of 0.41 as of Dec. 2025. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Haoxi Health Technology and its competitors.
Is Haoxi Health Technology's Cash Conversion Cycle too high?
Haoxi Health Technology's current Cash Conversion Cycle is 0.41. The Media - Diversified industry median Cash Conversion Cycle is 19.47. Haoxi Health Technology's value of 0.41 is 97.9% below this industry median. Overall, Haoxi Health Technology has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Haoxi Health Technology's Cash Conversion Cycle compare to BAOS and DBMM?
Haoxi Health Technology's Cash Conversion Cycle of 0.41 can be compared against companies in the Media - Diversified industry. The industry median Cash Conversion Cycle is 19.47. Haoxi Health Technology's value of 0.41 is 97.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Media - Diversified company?
The median Cash Conversion Cycle among Media - Diversified companies is 19.47, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Haoxi Health Technology's current Cash Conversion Cycle of 0.41 is 97.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Haoxi Health Technology and its competitors. For the Media - Diversified industry, the median Cash Conversion Cycle is 19.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Haoxi Health Technology's current Cash Conversion Cycle is 0.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haoxi Health Technology stock overvalued right now?
Haoxi Health Technology (HAO) has a current Cash Conversion Cycle of 0.41. The current Cash Conversion Cycle is 0.41 and 97.9% below the Media - Diversified industry median of 19.47. Haoxi Health Technology's overall GF Score™ is 21/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Haoxi Health Technology (HAO), the current Cash Conversion Cycle is 0.41 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Haoxi Health Technology Ltd is an online marketing solution provider in China, with an advertiser client base mainly in the healthcare industry. The company offers services that include planning, producing, placing, and optimizing online ads especially online short video ads, to help its advertisers acquire, convert, and retain ultimate consumers on various online media platforms. It places advertisements on popular digital platforms such as Toutiao, Douyin, WeChat, and Sina Weibo through media partners. Revenue is generated by providing comprehensive online marketing solutions. The company's operations center on digital advertising via mainstream video and social media channels in the Chinese market.
21GF Score
Get the complete analysis for HAO
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAO has been successfully added to your 
